Lijun Li
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: January 26, 2026
Tumor immune organoids in immunotherapy resistance and drug screening.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 04, 2025
Single-cell spatial analysis stratifies lung adenocarcinoma with rare actionable mutations and reveals immune-modulatory cellular crosstalk.
Journal: Cell reports. Medicine
Published: May 28, 2025
Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer.
Journal: Critical reviews in oncology/hematology
Published: June 06, 2024
Sleep disturbance as a poor prognostic predictor in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A prospective study.
Journal: Journal of psychosomatic research
Published: March 06, 2024
Influence of malnutrition according to the glim criteria on the chemotherapy toxicities in patients with advanced lung cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 18, 2024
Sarcopenia is an independent risk factor for depression in patients with advanced lung cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 08, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026